TY  - GEN
AU  - Guidi,L
AU  - Costanzo,M
AU  - Ciarniello,M
AU  - De Vitis,I
AU  - Pioli,C
AU  - Gatta,L
AU  - Pace,L
AU  - Tricerri,A
AU  - Bartoloni,C
AU  - Coppola,L
AU  - Balistreri,P
AU  - Doria,G
AU  - Fedeli,G
AU  - Gasbarrini,G B
TI  - Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment
SN  - 0394-6320
PY  - 2005///0714
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Blotting, Western
KW  - Crohn Disease
KW  - drug therapy
KW  - Female
KW  - Gastrointestinal Agents
KW  - Humans
KW  - I-kappa B Proteins
KW  - metabolism
KW  - Immunohistochemistry
KW  - Infliximab
KW  - Intestinal Mucosa
KW  - Male
KW  - Middle Aged
KW  - Monocytes
KW  - immunology
KW  - NF-KappaB Inhibitor alpha
KW  - NF-kappa B
KW  - antagonists & inhibitors
KW  - Peptide Fragments
KW  - Transcription Factors
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1177/039463200501800116
ER  -